Avricore Health Inc (AVCRF)
0.128
0.00 (0.00%)
USD |
OTCM |
Jun 17, 16:00
Avricore Health Enterprise Value: 12.57M for June 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 17, 2024 | 12.57M |
| June 14, 2024 | 12.77M |
| June 13, 2024 | 12.77M |
| June 12, 2024 | 12.77M |
| June 11, 2024 | 11.63M |
| June 10, 2024 | 11.42M |
| June 07, 2024 | 12.77M |
| June 06, 2024 | 12.77M |
| June 05, 2024 | 12.77M |
| June 04, 2024 | 11.97M |
| June 03, 2024 | 11.41M |
| May 31, 2024 | 10.96M |
| May 30, 2024 | 10.96M |
| May 29, 2024 | 10.96M |
| May 28, 2024 | 10.96M |
| May 24, 2024 | 10.96M |
| May 23, 2024 | 10.96M |
| May 22, 2024 | 10.96M |
| May 21, 2024 | 10.96M |
| May 20, 2024 | 10.96M |
| May 17, 2024 | 10.96M |
| May 16, 2024 | 12.17M |
| May 15, 2024 | 12.04M |
| May 14, 2024 | 12.04M |
| May 13, 2024 | 12.04M |
| Date | Value |
|---|---|
| May 10, 2024 | 12.04M |
| May 09, 2024 | 12.04M |
| May 08, 2024 | 12.04M |
| May 07, 2024 | 6.690M |
| May 06, 2024 | 6.690M |
| May 03, 2024 | 6.690M |
| May 02, 2024 | 6.690M |
| May 01, 2024 | 6.690M |
| April 30, 2024 | 6.690M |
| April 29, 2024 | 6.690M |
| April 26, 2024 | 6.705M |
| April 25, 2024 | 10.36M |
| April 24, 2024 | 10.36M |
| April 23, 2024 | 10.36M |
| April 22, 2024 | 10.36M |
| April 19, 2024 | 6.705M |
| April 18, 2024 | 6.705M |
| April 17, 2024 | 6.705M |
| April 16, 2024 | 6.705M |
| April 15, 2024 | 6.705M |
| April 12, 2024 | 6.705M |
| April 11, 2024 | 6.705M |
| April 10, 2024 | 6.705M |
| April 09, 2024 | 6.705M |
| April 08, 2024 | 6.705M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.5317M
Minimum
Nov 14 2019
31.19M
Maximum
Feb 12 2021
9.606M
Average
10.11M
Median
Aug 13 2021
Enterprise Value Benchmarks
| RadNet Inc | 4.834B |
| DermTech Inc | -27.35M |
| Centogene NV | 63.19M |
| iSpecimen Inc | 1.744M |
| 23andMe Holding Co | -20.39M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.0438M |
| Revenue (Quarterly) | 0.9949M |
| Total Expenses (Quarterly) | 0.9436M |
| Gross Profit Margin (Quarterly) | 37.02% |
| Profit Margin (Quarterly) | 4.40% |
| Earnings Yield | -5.70% |
| Normalized Earnings Yield | -5.614 |